Netherlands Focus Target Dutch pharma and biotech firms seeking end-to-end GMP readiness, CQV, and CMC/MSAT support, leveraging Progress expertise to accelerate manufacturing milestones within The Netherlands.

Compliance-Driven Value Position Progress as a pragmatic, high-value partner that reduces compliance risk for both global multinationals and startups, offering hands-on engineering, validation, and quality systems to shorten time to GMP-ready production.

Full Suite Offering Highlight the integrated service scope spanning engineering, CQV, CMC/MSAT, and QA/QC, enabling cross-functional teams to unify project delivery and minimize sourcing complexity for complex programs.

Small Firm Agility Leverage the mid-sized profile (51-200 employees) to offer flexible, fast-moving support with close collaboration, appealing to scale-ups and mid-size pharma players needing rapid responsiveness.

Digital & Reach Utilize existing tech stack and digital channels such as LinkedIn Ads and content marketing to generate targeted leads among Netherlands-based pharma/biotech companies actively seeking manufacturing scale-up expertise.